Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
2024 · Biomarker Research · 72 citations
https://doi.org/10.1186/s40364-023-00535-z
Y
Yanyu Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
944
Citations
16
h-index
27
i10-index
Yanyu Wang is an academic researcher from China University of Geosciences. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Pancreatic and Hepatic Oncology Research & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 16, co-authored 69 publications.
ORCID: 0000-0003-3365-3262Papers by this author
worksComparison of Baseline<sup>68</sup>Ga-FAPI and<sup>18</sup>F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
2023 · Journal of Nuclear Medicine · 42 citations
https://doi.org/10.2967/jnumed.123.265712
The Relationships Between Lipid Accumulation Product Levels and Cognitive Decline Over 4 Years in a Rural Area of Xi’an, China
2021 · Frontiers in Aging Neuroscience · 9 citations
https://doi.org/10.3389/fnagi.2021.761886
Fabrication of GDNF-Gel/HA-Mg nerve conduit and its role in repairing peripheral nerve defects
2025 · Materials Today Bio · 4 citations
https://doi.org/10.1016/j.mtbio.2025.101764
BclA significantly promoted spore persistence in the mouse lungs.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1005678.g004
Additional file 9 of Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13065698
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat